Targets | Drugs | Cancer type | NCT |
CSF1 | PD-0360324 |
| NCT02948101 |
PD-0360324 |
| NCT02554812 | |
CSF1R | Edicotinib |
| NCT03557970 |
| NCT03557970 | ||
TPX-0022 |
| NCT03993873 | |
Cabiralizumab |
| NCT03927105 | |
| NCT02471716 | ||
| NCT02526017 | ||
| NCT03502330 | ||
| NCT03927105 | ||
IMC-CS4 |
| NCT01346358 | |
| NCT03153410 | ||
| NCT01346358 | ||
SNDX-6352 |
| NCT03238027 | |
| NCT04301778 | ||
BLZ945 |
| NCT02829723 | |
ARRY-382 |
| NCT02880371 | |
| NCT01316822 | ||
Sunitinib |
| NCT02693535 | |
| NCT01265901 | ||
Nilotinib |
| NCT02029001 | |
DCC-3014 |
| NCT04242238 | |
| NCT03069469 | ||
| NCT03069469 | ||
PLX73086 |
| NCT02673736 | |
RG7155 |
| NCT02323191 | |
| NCT02760797 | ||
| NCT02923739 | ||
| NCT01494688 | ||
| NCT03369964 | ||
CSF-1R TKI | Pexidartinib |
| NCT02777710 |
PLX3397 |
| NCT02371369 | |
| NCT02584647 | ||
NMS-03592088 |
| NCT03922100 | |
CCR2/CCR5 | BMS-813160 |
| NCT04123379 |
| NCT03767582 | ||
| NCT03496662 | ||
| NCT02996110 | ||
CCR2 | MLN1202 |
| NCT01015560 |
PF-04136309 |
| NCT02732938 | |
CCX872-B |
| NCT02345408 | |
CCL2 | Carlumab |
| NCT00992186 |
CCL5 | Maraviroc |
| NCT01736813 |
| NCT02208037 | ||
Clodronate | Clodronate |
| NCT00009945 |
NCT00127205 | |||
NCT00873808 | |||
| NCT01198457 | ||
| NCT00909142 | ||
PI3Kγ | PI3K inhibitor |
| NCT04342117 |
BYL719 |
| NCT01791478 | |
| NCT01613950 | ||
BKM120 |
| NCT01816984 | |
| NCT01540253 | ||
| NCT01723800 | ||
| NCT01629615 | ||
RP6530 |
| NCT02017613 | |
PI3Kδ/γ | TGR-1202 |
| NCT02874404 |
Tenalisib |
| NCT03711578 | |
Duvelisib |
| NCT02598570 | |
| NCT04331119 | ||
| NCT02711852 | ||
| NCT04038359 | ||
| NCT03961672 | ||
| NCT03534323 | ||
| NCT04193293 | ||
| NCT02783625 | ||
| NCT03892044 | ||
| NCT03372057 | ||
| NCT04342117 | ||
| NCT04209621 | ||
TLR9 | Imiquimod |
| NCT02130323 |
NCT02329171 | |||
NCT00941252 | |||
NCT02669459 | |||
NCT02917746 | |||
| NCT00899574 | ||
| NCT01264731 | ||
| NCT00189306 | ||
| NCT00129519 | ||
NCT03534947 | |||
NCT00189241 | |||
NCT00463359 | |||
NCT00581425 | |||
NCT01212562 | |||
| NCT03276832 | ||
| NCT00031759 | ||
| NCT00204555 | ||
TLR7/8 | Resiquimod |
| NCT01676831 |
| NCT00470379 | ||
| NCT00821652 | ||
| NCT01748747 | ||
| NCT00948961 | ||
| NCT02126579 | ||
CD40 | Chi Lob 7/4 |
| NCT01561911 |
NG-350A |
| NCT03852511 | |
SGN-40 |
| NCT00664898 | |
| NCT00556699 | ||
ADC-1013 |
| NCT02379741 | |
2141 V-11 |
| NCT04059588 | |
Selicrelumab |
| NCT03892525 | |
HCD122 |
| NCT00231166 | |
EGFR TKI | Gefitinib |
| NCT03157310 |
Chloroquine | Chloroquine |
| NCT02333890 |
| NCT01777477 | ||
| NCT02432417 | ||
| NCT00224978 | ||
| NCT03243461 | ||
CD24 | CD24Fc |
| NCT04060407 |
CD47 | ZL1201 |
| NCT04257617 |
Hu5F9-G4 |
| NCT02678338 | |
| NCT02216409 | ||
| NCT03248479 | ||
| NCT02953782 | ||
| NCT03527147 | ||
| NCT02953509 | ||
IBI188 |
| NCT03717103 | |
NCT03763149 | |||
IBI322 |
| NCT04338659 | |
NCT04328831 | |||
HX009 |
| NCT04097769 | |
AO-176 |
| NCT03834948 | |
CC-90002 |
| NCT02367196 | |
AK117 |
| NCT04349969 | |
TTI-621 |
| NCT02663518 | |
| NCT02890368 | ||
| NCT03530683 | ||
SRF231 |
| NCT03512340 | |
ALX148 |
| NCT03013218 | |
SIRPα | Anti-SIRPα |
| NCT02868255 |
CD47-SIRPα | SRF231 |
| NCT03512340 |
CSF1, colony-stimulating factor 1; DLBCL, diffuse large B cell lymphoma; PI3K, phosphoinositide 3-kinase; TAMs, tumor-associated macrophages; TKI, tyrosine kinase inhibitor; TLR, toll-like receptor.